DE2337414C3 - 1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung - Google Patents

1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung

Info

Publication number
DE2337414C3
DE2337414C3 DE2337414A DE2337414A DE2337414C3 DE 2337414 C3 DE2337414 C3 DE 2337414C3 DE 2337414 A DE2337414 A DE 2337414A DE 2337414 A DE2337414 A DE 2337414A DE 2337414 C3 DE2337414 C3 DE 2337414C3
Authority
DE
Germany
Prior art keywords
imidazolidinone
chlorophenyl
ethyl
pharmaceutically acceptable
dimethylazetidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2337414A
Other languages
German (de)
English (en)
Other versions
DE2337414A1 (de
DE2337414B2 (de
Inventor
Luigi Fontanella
Giulio Maffii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of DE2337414A1 publication Critical patent/DE2337414A1/de
Publication of DE2337414B2 publication Critical patent/DE2337414B2/de
Application granted granted Critical
Publication of DE2337414C3 publication Critical patent/DE2337414C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2337414A 1972-07-26 1973-07-23 1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung Expired DE2337414C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2740472 1972-07-26

Publications (3)

Publication Number Publication Date
DE2337414A1 DE2337414A1 (de) 1974-02-07
DE2337414B2 DE2337414B2 (de) 1978-12-14
DE2337414C3 true DE2337414C3 (de) 1979-08-16

Family

ID=11221578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2337414A Expired DE2337414C3 (de) 1972-07-26 1973-07-23 1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung

Country Status (29)

Country Link
JP (1) JPS5120514B2 (enExample)
KR (1) KR780000092B1 (enExample)
AR (2) AR197051A1 (enExample)
AT (1) AT324324B (enExample)
AU (1) AU469020B2 (enExample)
BE (1) BE801726A (enExample)
CA (1) CA1000281A (enExample)
CH (1) CH577996A5 (enExample)
CS (1) CS185625B2 (enExample)
DD (1) DD107279A5 (enExample)
DE (1) DE2337414C3 (enExample)
DK (1) DK135377B (enExample)
ES (1) ES417269A1 (enExample)
FI (1) FI56006C (enExample)
FR (1) FR2193617B1 (enExample)
GB (1) GB1383619A (enExample)
HU (1) HU165566B (enExample)
IE (1) IE37803B1 (enExample)
IL (1) IL42518A (enExample)
LU (1) LU68084A1 (enExample)
NL (1) NL175822C (enExample)
NO (1) NO137785C (enExample)
PH (1) PH10236A (enExample)
PL (1) PL91619B1 (enExample)
RO (2) RO68382A (enExample)
SE (1) SE403378B (enExample)
SU (2) SU548211A3 (enExample)
YU (1) YU35253B (enExample)
ZA (1) ZA734081B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190721B (it) * 1982-03-09 1988-02-24 Lepetit Spa Derivati 3-azetidiniletil-1-fenil-2-imidazolidinici ad attivita' neurolettica,procedimento per la loro preparazione e loro impiego
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams

Also Published As

Publication number Publication date
IE37803B1 (en) 1977-10-12
ES417269A1 (es) 1976-03-16
SE403378B (sv) 1978-08-14
FR2193617A1 (enExample) 1974-02-22
IE37803L (en) 1974-01-26
NL7310325A (enExample) 1974-01-29
DD107279A5 (enExample) 1974-07-20
IL42518A (en) 1976-05-31
CA1000281A (en) 1976-11-23
GB1383619A (en) 1974-02-12
PL91619B1 (enExample) 1977-03-31
NO137785B (no) 1978-01-16
KR780000092B1 (en) 1978-04-08
AT324324B (de) 1975-08-25
PH10236A (en) 1976-10-08
JPS5120514B2 (enExample) 1976-06-25
DE2337414A1 (de) 1974-02-07
SU528870A3 (ru) 1976-09-15
DE2337414B2 (de) 1978-12-14
SU548211A3 (ru) 1977-02-25
FR2193617B1 (enExample) 1976-12-31
LU68084A1 (enExample) 1973-10-23
DK135377C (enExample) 1977-09-26
RO62909A (fr) 1978-01-15
HU165566B (enExample) 1974-09-28
BE801726A (fr) 1973-10-15
IL42518A0 (en) 1973-08-29
AU5739873A (en) 1975-01-09
AU469020B2 (en) 1976-01-29
DK135377B (da) 1977-04-18
NO137785C (no) 1978-04-26
AR197548A1 (es) 1974-04-15
JPS4943975A (enExample) 1974-04-25
CH577996A5 (enExample) 1976-07-30
FI56006C (fi) 1979-11-12
FI56006B (fi) 1979-07-31
ZA734081B (en) 1974-05-29
YU164973A (en) 1980-04-30
CS185625B2 (en) 1978-10-31
AR197051A1 (es) 1974-03-08
RO68382A (ro) 1981-11-24
YU35253B (en) 1980-10-31
NL175822C (nl) 1985-01-02

Similar Documents

Publication Publication Date Title
DE3248160C2 (de) 2-[4-[(4,4-Dialkyl-2,6-piperidindion-1-yl)-butyl]-1-piperazinyl]pyrimidine, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
DE3336024A1 (de) 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DD202152A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
DE3134929A1 (de) Derivate von theophyllin und theobromin
DE2901170C2 (enExample)
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE1620450C3 (de) 1 - (2- Hydroxybenzyl) -2-piperazinomethylbenzimidazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2712023A1 (de) Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
CH649995A5 (de) Piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DE3420193A1 (de) Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE2651083A1 (de) Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
DE2713441A1 (de) Amidinoharnstoffe
DE1445904A1 (de) Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
CH615914A5 (enExample)
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE2337414C3 (de) 1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung
EP0037495A1 (de) Pyrimidyl-chinazoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2847624A1 (de) Arylaether von n-alkyl-piperidinen und deren saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE2534963A1 (de) Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel
DE2658766C2 (de) 3-N-Pyrrolo-5-sulfamoylbenzoesäure-Derivate und Verfahren zu ihrer Herstellung
DE3004348A1 (de) In 4-stellung substituierte 2- iminoimidazolidinverbindungen
DE2254091C3 (de) Substituierte Aminoalkyl-guanidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)